Sex, Lies & Pharmaceuticals: How drug companies plan to profit from “female sexual dysfunction”

Text Size: Normal / Medium / Large
Printer-friendly versionPrinter-friendly version
Tue, 2010-12-14 12:00

The Canadian Women’s Health Network welcomes drug assessment specialist Dr. Barbara Mintzes to discuss the medicalization of women’s sexuality by pharmaceutical  companies. Mintzes will look at the ways women’s sexual difficulties are being repackaged as symptoms of a disorder called “female sexual dysfunction” in order to feed a marketing machine that promises to “cure” it. Mintzes will use examples from her research for  Sex, Lies and Pharmaceuticals to demonstrate how global drug companies are exploiting the exploration of women’s sexual dissatisfaction in an attempt to create the next billion dollar disease.

Click here to view the webinar

Mintzes is an Assistant Professor at the UBC Department of Pharmacology & Therapeutics, part of the UBC Centre for Health Services & Policy Research, and a Steering Committee member of Women and Health Protection.

Production of this event has been made possible through a financial contribution from Health Canada. The views expressed herein do not necessarily represent the views of Health Canada.

Best of CWHN: 
Best of CWHN